Notably, we found that autophagy was significantly activated along with an increased LC3 II/I ratio and degradation of p62 after metformin treatment in cervical cancer (HeLa), prostate cancer (PC‐3) and breast cancer (MDA‐MB‐231) cells (Figure S4), which is in accordance with other studies. The gene discussed is MAP1LC3A; the disease is cervical cancer.